Omnicell Announces Financial Results for Third Quarter 2022

Go back to Omnicell Announces Financial Results for Third Quarter 2022

Benchmark Downgrades Omnicell (OMCL) to Hold

November 3, 2022 6:11 AM EDT

Benchmark analyst Bill Sutherland downgraded Omnicell (NASDAQ: OMCL) from Buy to Hold.

The analyst comments "Yesterday, OMCL shocked investors with downwardly revised 2022 expectations that included a 29% drop in 2022 product bookings and implied 4Q22 revenue and non-GAAP EBITDA declines of 7% and 76%, respectively. Nearly the entire problem relates to the XT automated dispensing cabinets (ADCs), which represent over half of total product bookings and, unlike the rest... More

Omnicell (OMCL) Tops Q3 EPS by 5c; Lowers Outlook

November 2, 2022 8:30 AM EDT

Omnicell (NASDAQ: OMCL) reported Q3 EPS of $1.00, $0.05 better than the analyst estimate of $0.95. Revenue for the quarter came in at $348 million versus the consensus estimate of $363.24 million.

GUIDANCE:

Omnicell sees Q4 2022 EPS of $0.05-$0.15, versus the consensus of $1.21. Omnicell sees Q4... More